VYNE Therapeutics Inc.
VYNE
$1.43
-$0.45-23.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.52M | 70.19M | 78.10M | 85.95M | 93.25M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.92M | 3.30M | 5.63M | 4.22M | 2.66M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 47.00K | 46.00K | 54.00K | 54.00K |
| Total Current Assets | 64.44M | 73.54M | 83.78M | 90.22M | 95.96M |
|
|
|||||
| Total Current Assets | 64.44M | 73.54M | 83.78M | 90.22M | 95.96M |
| Net Property, Plant & Equipment | 206.00K | 122.00K | 151.00K | 180.00K | 207.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.26M | 2.54M | 2.72M | 1.27M | 1.52M |
| Total Assets | 66.91M | 76.20M | 86.65M | 91.68M | 97.69M |
|
|
|||||
| Total Accounts Payable | 2.71M | 3.99M | 4.52M | 2.80M | 1.66M |
| Total Accrued Expenses | 8.59M | 7.24M | 3.71M | 1.62M | 3.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 99.00K | 123.00K | 120.00K | 117.00K | 115.00K |
| Total Finance Division Other Current Liabilities | 3.42M | 1.31M | 3.41M | 2.40M | 2.25M |
| Total Other Current Liabilities | 3.42M | 1.31M | 3.41M | 2.40M | 2.25M |
| Total Current Liabilities | 14.82M | 12.66M | 11.75M | 6.93M | 7.54M |
|
|
|||||
| Total Current Liabilities | 14.82M | 12.66M | 11.75M | 6.93M | 7.54M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 25.00K | 63.00K | 99.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 1.31M | 1.31M |
| Total Liabilities | 14.82M | 12.66M | 11.78M | 8.31M | 8.95M |
|
|
|||||
| Common Stock & APIC | 783.24M | 782.65M | 781.92M | 781.03M | 780.05M |
| Retained Earnings | -731.17M | -719.15M | -706.99M | -697.59M | -691.34M |
| Treasury Stock & Other | 20.00K | 34.00K | -58.00K | -70.00K | 26.00K |
| Total Common Equity | 52.09M | 63.54M | 74.87M | 83.37M | 88.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 52.09M | 63.54M | 74.87M | 83.37M | 88.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 52.09M | 63.54M | 74.87M | 83.37M | 88.74M |
|
|
|||||